TipRanks
Go Ultimate55% OFF

Drdgold (DUBA) Stock Price & Analysis

DUBA Stock Chart & Stats

€21.40€0.00(0.00%)
At close: 5:30 PM GMT+1
€17.5€20€22.5€2511 Aug24 Aug8 Sep16 Sep29 Sep19 Oct
Day’s Range
EUR 21.40 - EUR 21.40
52-Week Range
EUR 17.00 - EUR 33.60
Previous Close
EUR 21.40
Volume
0
Average Volume (3M)
27
Market Cap
EUR 1.77B
Enterprise Value
EUR 1.69B
Total Cash (Recent Filing)
EUR 2.75B
Total Debt (Recent Filing)
EUR 11.31M
Price to Earnings (P/E)
7.8
Beta
0.88
Next Earnings
Feb 17, 2027 (Est.)
EPS Estimate
N/A
Next Dividend Ex-Date
N/A
Dividend Yield
4.17%

Bulls Say, Bears Say

Bulls Say

Debt-free Balance Sheet

An exceptionally conservative balance sheet gives DRDGOLD financial flexibility to fund growth, absorb operating volatility, and avoid material interest burdens. Improving returns on equity also indicate that the company is deploying its asset base effectively, supporting durable capital allocation capacity.

Strong Growth And Margins

Accelerating revenue growth alongside substantial gross and net margin expansion demonstrates strong operating leverage in the tailings retreatment model. Higher profitability can strengthen internally funded investment, improve resilience against cost pressure, and support earnings generation over multiple quarters.

Expansion Capacity And Execution

Completed facilities and advancing infrastructure provide a tangible pathway to higher throughput and production without relying on debt financing. Daggafontein, DP2 and RTSF milestones also show execution against Vision 2028, which can extend operating capacity and sustain the business model.

Bears Say

Gold-price Earnings Exposure

A substantial share of recent revenue and profit improvement came from the realized gold price rather than major volume growth. This leaves earnings, margins and cash generation exposed to future commodity-price movements, making sustained performance less predictable across the cycle.

Capital Intensity And Uneven Cash Flow

Large investment requirements can absorb a meaningful portion of accounting earnings even when operating cash generation is strong. Uneven free cash flow reduces flexibility for dividends and discretionary investment, while continued capital intensity makes cash conversion an important ongoing constraint.

Project Approval And Timing Risk

Delays to Withok or RTSF could postpone planned throughput and cash-flow benefits, particularly as Withok is strategically important for sustaining Ergo’s production profile from 2030. The projects therefore carry longer-term execution and regulatory timing risk despite current progress.

Drdgold News

DUBA FAQ

What was Drdgold’s price range in the past 12 months?
Drdgold lowest stock price was €17.00 and its highest was €33.60 in the past 12 months.
What is Drdgold’s market cap?
Drdgold’s market cap is €1.77B.
When is Drdgold’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Drdgold’s earnings last quarter?
Drdgold released its earnings results on Aug 19, 2026. The company reported €1.455 earnings per share for the quarter.
Is Drdgold overvalued?
According to Wall Street analysts Drdgold’s price is currently Undervalued.
Does Drdgold pay dividends?
Drdgold does not currently pay dividends.
What is Drdgold’s EPS estimate?
Drdgold’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Drdgold have?
Drdgold has 86,875,656 shares outstanding.
What happened to Drdgold’s price movement after its last earnings report?
Drdgold reported an EPS of €1.455 in its last earnings report. Following the earnings report the stock price went down -0.954%.
Which hedge fund is a major shareholder of Drdgold?
Hedge funds hold Drdgold shares: the largest hedge-fund position in Drdgold is 1,949,673,895 shares, and hedge funds decreased their holdings by 20.7K shares last quarter.
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology